CEO Jacob Thaysen on Tuesday made clear that the sequencing firm, which controls about 80% of the current DNA-sequencer market, is essentially returning to its traditional role of creating ...

Illumina said on Tuesday it has partnered with the Broad Institute to develop new kits that will allow large-scale gene sequencing using a novel method based on the Nobel Prize-winning CRISPR ...

CEO Jacob Thaysen sees Illumina on track to meet his original goal of high single-digit revenue growth by 2027 despite ...

Illumina is a global leader in developing the tools that help scientists analyze strands of DNA as well as large amounts of complex genetic data through multiomic sequencing.

According to Strömqvist, this format enables 3D DNA sequencing in situ. The size of Single Technologies’ 3D DNA sequencing matrix (left) compared to Illumina’s S4 flow cell (right).

An Illumina NovaSeq X Plus sequencer completes its run at an MSK lab. This machine can sequence 25 to 50 billion molecules in a single run, which takes two days, according to Dr. Neeman Mohibullah, ...

Illumina Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today the appointment ...

The cost of DNA sequencing has been dropping for years. Since the $1000 genome claim, first made by Illumina in 2014, multiple companies have claimed a $100 genome, including Ultima Genomics—a ...